The RNA-editing technology, an alternative to DNA-editing tool CRISP-Cas9, potentially opens the doorway to RNA as a druggable target
Philips Unveils Expanded Visualization Platform, Leads Liquid Biopsy/MRI Consortium in Winning EU Grant
Royal Philips launches next-gen IntelliSpace Portal 10 platform and leads liquid biopsy/MRI consortium in winning $7.5M from EU
Astute gains wider access to Bio-Techne's antibody and protein libraries, and Bio-Techne receives manufacturing rights for future products.
Already strong in the hospital pathology arena, the deal will expand NeoGenomics' presence with community oncology practices
The researchers studied changes in gene expression and identified 11 cell types that could provide new insights of male infertility
The new array will be a high-density chip designed to enable achievement of the research program's primary genotyping-based goals
ZS' technology employs electron microscopy for reads of 50,000 plus base pairs, reduces sampling which may lower informatics and data costs.
Personalized treatment, guided by the Oncotype DX test, could lower the initial cost of early breast cancer care in the United States by approximately...
The FTC will allow Abbott’s $5.3 billion acquisition of Alere, which in return will sell its blood gas and cardiac marker businesses.
PerkinElmer entered an agreement to serve as the exclusive collaborator with China's National Health and Family Planning Commission in developing and implementing an extensive...